Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment

Intern Emerg Med. 2021 Mar;16(2):519-520. doi: 10.1007/s11739-020-02373-5. Epub 2020 May 21.

Authors

Attilio Allione¹, Jacopo Davide Giamello², Giulia Paglietta³, Sara Bernardi¹, Giulia Cavalot¹

Affiliations

¹ Department of Emergency Medicine, Santa Croce and Carle Hospital, Cuneo, Italy.
² School of Emergency Medicine, University of Turin, Turin, Italy. jacopo.giamello@gmail.com.
³ School of Emergency Medicine, University of Turin, Turin, Italy.

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticoagulants / adverse effects
Antiviral Agents / therapeutic use
COVID-19*
Heparin / adverse effects
Humans
SARS-CoV-2*

Substances

Anticoagulants
Antiviral Agents
Heparin